Delivery Order SPE2DB22D1017-SPE2DB25FG8TE
- Not listed
- The Defense Logistics Agency awarded a $4,204.20 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors with a completion date of September 5, 2025. This firm fixed-price, non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a $5,762.58 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,086.58 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a $1,938.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors with a completion date of August 8, 2025. This non-competitive, non-set-aside delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the company's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,402.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen injections on July 18, 2025, with completion targeted for July 21, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $1,178.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This is a non-set-aside contract with an ultimate completion date of August 13, 2025, and performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors valued at $1,218.01, with completion scheduled for August 22, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical transaction within the broader federal medical supply chain. The contract specifies performance at AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors with a ceiling value of $8,630.84. This firm fixed-price delivery order, which is set to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The medication will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order valued at $4,285.58 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors (0.5 mL). This firm fixed-price, non-set-aside contract is set to be completed by August 18, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $2,402.10. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is scheduled for completion by August 26, 2025, just one day after the award date of August 25, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8TEDelivery Order
The Defense Logistics Agency awarded a $2,260.85 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen injectors on August 1, 2025, with completion scheduled for August 4, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls within AmerisourceBergen's extensive portfolio of federal pharmaceutical supply contracts supporting military and veteran healthcare systems. As a major healthcare solutions provider and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical supplies through its DLA prime vendor agreement, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The company's competitively awarded contracts demonstrate its capability to fulfill diverse federal medical supply requirements, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/1/25 |